This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Vladislav Kisselev: Innovator in Acylated Insulin Compounds
Introduction
Vladislav Kisselev is a notable inventor based in Carmel, Indiana. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin compounds. His innovative work has led to the creation of a patent that addresses important medical needs.
Latest Patents
Kisselev holds a patent for "Extended Time Action Acylated Insulin Compounds." This invention aims to improve the delivery and effectiveness of insulin for patients with diabetes. The patent represents a crucial advancement in diabetes management, providing patients with better control over their condition.
Career Highlights
Vladislav Kisselev is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly has allowed him to work on groundbreaking research and development projects. Kisselev's expertise in insulin compounds has positioned him as a key player in the pharmaceutical industry.
Collaborations
Kisselev collaborates with Seamus Patrick Brennan, a fellow innovator in the field. Together, they work on advancing the science of insulin delivery and improving patient outcomes. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Vladislav Kisselev's contributions to the field of insulin compounds highlight his dedication to improving healthcare. His patent and work at Eli Lilly and Company demonstrate the impact of innovation in the pharmaceutical industry. Kisselev's efforts continue to pave the way for advancements in diabetes treatment.